Company Filing History:
Years Active: 2010
Title: Rebecca A Kohnz: Innovator in Cancer Diagnosis and Treatment
Introduction
Rebecca A Kohnz is a prominent inventor based in Cold Spring Harbor, NY (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of various cancers. Her innovative work has the potential to improve patient outcomes and advance medical science.
Latest Patents
Rebecca A Kohnz holds a patent titled "Role of FGF-20 in cancer diagnosis and treatment." This invention provides methods for diagnosing cancers in humans by detecting DNA amplifications in the chromosomal region 8p22, which encompasses the FGF-20 gene and the EFHA2 gene. Additionally, the patent outlines cancer treatment methods using inhibitors of FGF-20 and EFHA2. It also includes methods for promoting successful regeneration of liver function, which can be therapeutically applied to improve liver function following transplantation in both recipient and donor subjects. She has 1 patent to her name.
Career Highlights
Rebecca is affiliated with Cold Spring Harbor Laboratory, where she conducts her research and develops her innovative ideas. Her work is recognized for its potential impact on cancer diagnostics and treatment methodologies.
Collaborations
Rebecca collaborates with esteemed colleagues, including Scott Powers and Lars Zender, who contribute to her research endeavors and enhance the scope of her work.
Conclusion
Rebecca A Kohnz is a trailblazer in the field of cancer research, with her innovative patent offering promising methods for diagnosis and treatment. Her contributions are vital to advancing medical science and improving patient care.